Fulcrum Therapeutics, Inc.
US ˙ NasdaqGM ˙ US3596161097

SecurityFULC / Fulcrum Therapeutics, Inc.
InstitutionBessemer Group Inc
Latest Disclosed Ownership286,988 shares
Latest Disclosed Value $ 2,201
Bessemer Group Inc ownership in FULC / Fulcrum Therapeutics, Inc.

On May 6, 2026 - Bessemer Group Inc filed a 13F-HR form disclosing ownership of 286,988 shares of Fulcrum Therapeutics, Inc. (US:FULC) valued at $2,201,198 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 286,988 shares of Fulcrum Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,058,986 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 2 -33.33 0.0035
2026-02-05 2025-12-31 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 3 50.00 0.0050
2025-11-05 2025-09-30 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 3 100.00 0.0040
2025-08-01 2025-06-30 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 2 0.0032
2025-04-23 2025-03-31 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 1 -100.00 0.0015
2025-02-13 2024-12-31 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 1 0.00 0.0022
2024-11-12 2024-09-30 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 1 0.00 0.0017
2024-08-13 2024-06-30 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 2 -50.00 0.0031
2024-08-13 2024-03-31 13F/A-1 FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 3 100.00 0.0049
2024-05-13 2024-03-31 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 3 0.0049
2024-02-09 2023-12-31 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 2 0.00 0.0038
2023-11-13 2023-09-30 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 1 0.0028
2023-08-10 2023-06-30 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 1 0.0020
2023-05-10 2023-03-31 13F FULCRUM THERAPEUTICS SC 359616109 286,988 0 0.00 1 -100.00 0.0019
2023-02-13 2022-12-31 13F FULCRUM THERAPEUTICS SC 359616109 286,988 1,274 0.45 2 -99.91 0.0051
2022-11-09 2022-09-30 13F FULCRUM THERAPEUTICS SC 359616109 285,714 0 0.00 2,311 65.07 0.0060
2022-08-10 2022-06-30 13F FULCRUM THERAPEUTICS SC 359616109 285,714 0 0.00 1,400 -79.28 0.0035
2022-05-12 2022-03-31 13F FULCRUM THERAPEUTICS SC 359616109 285,714 -23,707 -7.66 6,757 23.44 0.0142
2022-01-27 2021-12-31 13F FULCRUM THERAPEUTICS SC 359616109 309,421 -1,197 -0.39 5,474 -37.53 0.0110
2021-11-12 2021-09-30 13F FULCRUM THERAPEUTICS SC 359616109 310,618 24,904 8.72 8,762 192.65 0.0187
2021-08-06 2021-06-30 13F FULCRUM THERAPEUTICS SC 359616109 285,714 0 0.00 2,994 -11.05 0.0065
2021-05-13 2021-03-31 13F FULCRUM THERAPEUTICS SC 359616109 285,714 0 0.00 3,366 0.60 0.0081
2021-02-09 2020-12-31 13F FULCRUM THERAPEUTICS SC 359616109 285,714 0 0.00 3,346 47.66 0.0088
2020-11-12 2020-09-30 13F FULCRUM THERAPEUTICS SC 359616109 285,714 0 0.00 2,266 -56.64 0.0067
2020-08-05 2020-06-30 13F FULCRUM THERAPEUTICS SC 359616109 285,714 0 0.00 5,226 53.21 0.0165
2020-04-30 2020-03-31 13F FULCRUM THERAPEUTICS SC 359616109 285,714 0 0.00 3,411 -28.25 0.0137
2020-02-04 2019-12-31 13F FULCRUM THERAPEUTICS SC 359616109 285,714 0 0.00 4,754 150.61 0.0154
2019-11-07 2019-09-30 13F FULCRUM THERAPEUTICS SC 359616109 285,714 285,714 1,897 0.0068
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.